Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.64 and last traded at $2.70, with a volume of 10164 shares traded. The stock had previously closed at $2.88.
Hypera Stock Down 7.4 %
The company has a market cap of $1.74 billion, a price-to-earnings ratio of 5.23 and a beta of 1.02. The firm has a 50-day simple moving average of $3.74 and a 200 day simple moving average of $4.70.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- How to Capture the Benefits of Dividend Increases
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Bank Stocks – Best Bank Stocks to Invest In
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Using the MarketBeat Dividend Tax Calculator
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
